Bandingkan Harga & Kinerja Resource Alam Indonesia Tbk (KKGI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Resource Alam Indonesia Tbk dan Organon Pharma Indonesia Tbk.: Resource Alam Indonesia Tbk diperdagangkan di Rp302 (kapitalisasi pasar 1,51 T, volume 24 jam 2,44 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Resource Alam Indonesia Tbk jauh lebih besar — sekitar 14,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KKGI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,51 T | 104,4 M |
Volume | 2,44 jt | — |
Lot | 24,4 rb | — |
Perputaran | 733,28 jt | — |
Harga Rata-rata | 300,5 | — |
Nilai Transaksi | 733,28 jt | — |
Harga Ekuilibrium Indikatif | 302 | — |
Volume Ekuilibrium Indikatif | 5 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Resource Alam Indonesia Tbk
PT Resource Alam Indonesia Tbk (the Company) was originally established under the name PT Kurnia Kapuas Utama Glue Industries (which was subsequently changed to PT Kurnia Kapuas Utama Tbk). PT Kurnia Kapuas Glue industries founded in 1981 in Pontianak, West Kalimantan and produces formalin and resin. The company supplies glue for plywood factories within the Bumi Raya Utama Group (BRU Group). The company is domestic investment.
Selengkapnya di halaman KKGI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
